National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.
National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.
The End Brain Cancer Initiative is pleased to announce that Alyssa Gohra is the 2023 National HOPE Award winner.
Each May the EndBrainCancer Initiative, in Partnership with Novocure, has presented the HOPE award to brain cancer patients who deeply inspire us with their courage and story.
If you have been diagnosed with rGBM (first recurrence only), would you like to participate in a PAID short interview?
Join our virtual event on May 19th featuring Dr. Thomas Lechner.
In decentralized Clinical Trials some or all trial-related procedures and compiling of patient and trial data takes place at locations/sites that are remote from the Principal Investigator.
The new EBCI app is the fastest way to learn of new treatment options, trials, events, webinars, research updates, and so much more!
Children's Brain Tumor Foundation has developed a series of Support Group Events in the month of March to address the needs of various patients, family members, and caregivers.
"When Randy Cordova was first diagnosed with a glioblastoma brain tumor, the news, he says, was earth-shaking. He and his wife Maura cried, prayed and committed to beating it. ...
This webinar is open to anyone interested in attending. We encourage Oncology Nurses, Navigation Nurses, Genetic Counselors, Oncologists, Patient Advocates / Caregivers and Patients to attend. May 12, 2023
This webinar will explore evidence-supported lifestyle and dietary therapies to promoted physical and mental wellbeing. Feb. 23, 2023
This Month, I’d like to introduce you to the company, Reglagene, www.reglagene.com, a therapeutics company located in Tucson, AZ transforming tubulin targeting therapy for CNS diseases.